+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genetic Testing. Global Market Forecasts for Applications and Technologies. Updated for COVID-19 Pandemic impact with Executive and Consultant Guides 2020 to 2024

  • ID: 5078157
  • Report
  • November 2020
  • Region: Global
  • 429 Pages
  • Howe Sound Research
1 of 4
Genetic Blizzard of New Tests drives Global Growth.

FEATURED COMPANIES

  • 23andME Inc
  • BioGenex
  • Excellerate Bioscience
  • Grifols
  • Medgenome
  • Personalis
  • MORE

Report Overview:

Large genetic testing cancer segment impacted by COVID-19. Genetic Blizzard creating a confusing array of new tests.

Will all newborns receive Whole Genomic Sequencing at birth? What has happened to Direct to Consumer?

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating a new life for the industry. The report forecasts the market size out to 2024. The report includes detailed breakouts for 14 countries and 5 regions.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 23andME Inc
  • BioGenex
  • Excellerate Bioscience
  • Grifols
  • Medgenome
  • Personalis
  • MORE

Genetic Testing - Strategic Situation Analysis & Impact of COVID-19 Pandemic

  • Guide for Executives, Marketing, Sales and Business Development Staff
  • Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition
1.1 Genetic Testing Definition in This Report
1.2 The Genomics Revolution
1.3 Market Definition
1.3.1 Revenue Market Size
1.3.1 Newborn Screening
1.3.2 Non Invasise Pregnancy Testing
1.3.3 Predictive
1.3.4 Oncology
1.3.5 Direct to Consumer
1.3.6 Other Application
1.3.7 PCR
1.3.4 NGS
1.3.5 Cytogenetic
1.3.6 Other Technology
1.4 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for Laboratory Testing

2. Market Overview
2.1 Market Participants Play Different Roles
2.1.1 Supplier/pharmaceutical
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 DTC Lab
2.1.9 Independent Genetic Testing Lab
2.1.10 Audit Body
2.2 Genetic Tests -Types, Examples and Discussion
2.2.1 Preimplantation Genetic Diagnosis- An Emerging Market
2.2.2 Prenatal Diagnosis - New Technologies Create Opportunity
2.2.3 Newborn Screening
2.2.2 Diagnostic Testing
2.2.3 Carrier Testing
2.2.6 Predictive and Presymptomatic Testing
2.2.7 Pharmacogenomics
2.2.8 Forensic Testing
2.2.9 Parental Testing
2.2.10 Ancestral Testing
2.3 Industry Structure
2.3.1 Hospital’s Testing Share
2.3.2 Economies of Scale
2.3.2.1 Hospital vs. Central Lab
2.3.3 Physician Office Lab’s
2.3.4 Physician’s and POCT
2.4 Market Shares of Key Genetics Players - Analysis

3. Market Trends
3.1 Factors Driving Growth
3.1.1 Genetic Discoveries Creating New Diagnostic Markets
3.1.2 Aging Population a Boon for Diagnostics
3.1.3 Pharmacogenomics Drives Further Growth
3.1.4 Oncology and Liquid Biopsy Enter New Era
3.1.5 Fertility Practice Growth drives market
3.1.6 Direct to Consumer begins to break out
3.2 Factors Limiting Growth
3.2.1 Increased Competition Lowers Price
3.2.2 Lower Costs
3.2.3 Testing usage analysis curtailing growth
3.2.4 Wellness has a downside
3.3 Instrumentation and Automation
3.3.1 Instruments Key to Market Share
3.3.2 Bioinformatics Plays a Role
3.4 Diagnostic Technology Development
3.4.1 Next Generation Sequencing Fuels a Revolution
3.4.2 Impact of NGS on pricing
3.4.3 POCT/Self Testing Disruptive Force
3.4.4 Pharmacogenomics Blurs Diagnosis and Treatment
3.4.5 CGES Testing, A Brave New World
3.4.6 Biochips/Giant magneto resistance based assay

4. Genetic Testing Recent Developments
4.1.1 Importance of This Section
4.1.2 How to Use This Section

  • Preconception Carrier Screening Trial Begins in Australia
  • Genetic Testing Clinical Use Just Beginning
  • Fulgent Genetics Q1 Revenues Jump 44 Percent
  • Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders
  • Natera Terminates Qiagen Agreement for Developing NGS-Based Genetic Tests
  • Invitae Acquires Three Companies: YouScript, Genelex, Diploid
  • Thermo Fisher Scientific to Buy Qiagen for $11.5B
  • PerkinElmer SCID Test Chosen for Newborn Screening Evaluation in England
  • Germline Cancer Risk Mutations Sometimes Reported in Tumor Testing
  • Blueprint Genetics, Archimedlife to Launch Genetic Testing in North America
  • Invitae to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients
  • Phosphorus Offers DNA Testing to Assess Disease Risk
  • Arivale Shuts Down Personalized Wellness Business
  • ArcherDX Acquires Baby Genes
  • MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay
  • Thermo Fisher Purchases 9 Percent Stake in Yourgene Health
  • Invitae Partners to Expand Free Epilepsy Genetic Testing Program
  • Illumina, Chinese Firm Partner on NGS System for Genetic Disease Dx
  • NanoString Technologies Prices $103.5M Common Stock Offering
  • Canine Consumer Genomics Firm Embark Veterinary Raises $10M
  • Yourgene Health to Acquire Elucigene
  • Helix, AdventHealth Partner on Genetic Screening Study
  • Qiagen, NeuMoDx Ink Partnership, Merger Agreement

5. Profiles of Key Companies

  • Genomics, Inc
  • 23andME Inc
  • Abbott Diagnostics
  • AccuraGen Inc
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agena Bioscience, Inc
  • Agilent
  • Akonni Biosystems
  • Ancestry.com LLC
  • Anchor Dx
  • ArcherDx, Inc
  • ARUP Laboratories
  • Asuragen
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter, Inc
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocept, Inc
  • Biodesix Inc
  • BioFluidica
  • BioGenex
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Cancer Genetics
  • Caris Molecular Diagnostics
  • CellMax Life
  • Centogene
  • Chronix Biomedical
  • Circulogene
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics, Inc. - A BGI Company
  • Cynvenio
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Excellerate Bioscience
  • Exosome Diagnostics
  • Fabric Genomics
  • Fluidigm Corp
  • Foundation Medicine
  • Freenome
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • GE Global Research
  • GE Healthcare Life Sciences
  • Gene by Gene, Ltd
  • Genedrive
  • GeneFirst Ltd
  • Genetron Health (Beijing) Co., Ltd
  • Genewiz
  • Genomic Health
  • Genomics England
  • Genomics Personalized Health (GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grail, Inc
  • Grifols
  • Guardant Health
  • Guardiome
  • HeiScreen
  • Helix
  • Helomics
  • Hologic
  • Horizon Discovery
  • HTG Molecular Diagnostics
  • Human Longevity, Inc. iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Macrogen
  • MDNA Life SCIENCES, Inc
  • MDx Health
  • Medgenome
  • Meridian Bioscience
  • Mesa Biotech
  • MIODx
  • miR Scientific
  • MNG Labs
  • Molecular MD
  • NantHealth, Inc
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • New Oncology
  • Novogene Bioinformatics Technology Co., Ltd
  • Omega Bioservices
  • OncoDNA
  • ORIG3N, Inc
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Panagene
  • Perkin Elmer
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • PrecisionMed
  • Promega
  • Protagen Diagnostics
  • Qiagen Gmbh
  • Quantumdx
  • Regeneron
  • Roche Molecular Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sequencing.com
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc
  • SkylineDx
  • Stratos Genomics
  • Sure Genomics, Inc
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc
  • Thermo Fisher Scientific Inc
  • Veritas Genetics
  • Volition

6. Global Market Size
6.1 Global Market by Country
6.1.1 Table - Global Market by Country
6.1.2 Chart - Key Country Densities
6.2 Global Market by Application
6.2.1 Table - Global Market by Application
6.2.2 Chart - Application Share by Year
6.2.3 Chart - Application Segment Growth Rates
6.2.4 Chart - Application Segment Share Shifts
6.2.5 Chart - Application Segment Share Base Year
6.2.6 Chart - Application Segment Share Final Year
6.3 Global Market by Technology
6.3.1 Table - Global Market by Technology
6.3.2 Chart - Technology Share by Year
6.3.3 Chart - Technology Segment Growth Rates
6.3.4 Chart - Technology Segment Share Shifts
6.3.5 Chart - Technology Segment Share Base Year
6.3.6 Chart - Technology Segment Share Final Year

7. Market Sizes by Application
7.1 Newborn Testing Market
7.1.1 Table Newborn - by Country
7.1.2 Chart - Newborn Growth
7.2 NIPT Market
7.2.1 Table NIPT - by Country
7.2.2 Chart - NIPT Growth
7.3 Predictive Testing Market
7.3.1 Table Predictive - by Country
7.3.2 Chart - Predictive Growth
7.4 Oncology Testing Market
7.4.1 Table Oncology - by Country
7.4.2 Chart - Oncology Growth
7.5 DTC Testing Market
7.5.1 Table DTC - by Country
7.5.2 Chart - DTC Growth
7.6 Other Testing Market
7.6.1 Table Other - by Country
7.6.2 Chart - Other Growth

8. Global Genetic Testing Market by Technology
8.1 PCR Testing Market
8.1.1 Table PCR - by Country
8.1.2 Chart - PCR Growth
8.2 NGS Market
8.2.1 Table NGS - by Country
8.2.2 Chart - NGS Growth
8.3 Cytogenetic Testing Market
8.3.1 Table Cytogenetic - by Country
8.3.2 Cytogenetic - Predictive Growth
8.4 Other Testing Market
8.4.1 Table Other - by Country
8.4.2 Chart - Other Growth

9. The Future of Genetic Testing

Appendices

I. United States Medicare System: January 2020 Laboratory Fees Schedule

II Methodology
II.1 Authors
II.2 Sources

List of Tables

Table 1 Most Common Traditional Genetic Disorders
Table 2 Lab Spending 2014 to 2024
Table 3 Market Players by Type
Table 4 The Different Types of Genetic Tests
Table 5 Five Factors Driving Growth
Table 6 Four Factors Limiting Growth
Table 7 Key Diagnostic Laboratory Technology Trends
Table 8 Next Generation Sequencing Technologies - Speed and Cost
Table 9 Global Market by Country
Table 10 Global Market by Application
Table 11 Global Market by Technology
Table 12 Newborn Segment by Country
Table 13 NIPT Segment by Country
Table 14 Predictive Segment by Country
Table 15 Oncology Segment by Country
Table 16 DTC Segment by Country
Table 17 Other Segment by Country
Table 18 PCR Segment by Country
Table 19 NGS Segment by Country
Table 20 Cytogenetic Segment by Country
Table 21 Other Segment by Country
Table 22 2020 CLINICAL LAB FEE SCHEDULE

List of Figures

Figure 1 Clinical Lab Spending 2014 to 2024
Figure 2 Top Ten Sequencing Companies
Figure 3 Percentage of World Population Over 65
Figure 4 Key Countries
Figure 5 Application Share by Year
Figure 6 Application Segment Growth Rates
Figure 7 Segment Share Shifts
Figure 8 Application Segment Share Base Year
Figure 9 Application Segment Share Final Year
Figure 10 Technology Share by Year
Figure 11 Technology Segment Growth Rates
Figure 12 Technology Segment Share Shifts
Figure 13 Technology Segment Share Base Year
Figure 14 Technology Segment Share Final Year
Figure 15 Newborn vs. Total Market Growth
Figure 16 NIPT vs. Total Market Growth
Figure 17 Predictive vs. Total Market Growth
Figure 18 Oncology vs. Total Market Growth
Figure 19 DTC vs. Total Market Growth
Figure 20 Other vs. Total Market Growth
Figure 21 PCR vs. Total Market Growth
Figure 22 NGS vs. Total Market Growth
Figure 23 Cytogenetic vs. Total Market Growth
Figure 24 Other vs. Total Market Growth

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 23andME Inc
  • Abbott Diagnostics
  • AccuraGen Inc
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agena Bioscience, Inc
  • Agilent
  • Akonni Biosystems
  • Ancestry.com LLC
  • Anchor Dx
  • ArcherDx, Inc
  • ARUP Laboratories
  • Asuragen
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter, Inc
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Bioarray Genetics
  • Biocept, Inc
  • Biodesix Inc
  • BioFluidica
  • BioGenex
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Cancer Genetics
  • Caris Molecular Diagnostics
  • CellMax Life
  • Centogene
  • Chronix Biomedical
  • Circulogene
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics, Inc. - A BGI Company
  • Cynvenio
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Excellerate Bioscience
  • Exosome Diagnostics
  • Fabric Genomics
  • Fluidigm Corp
  • Foundation Medicine
  • Freenome
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • GE Global Research
  • GE Healthcare Life Sciences
  • Gene by Gene, Ltd
  • Genedrive
  • GeneFirst Ltd
  • Genetron Health (Beijing) Co., Ltd
  • Genewiz
  • Genomic Health
  • Genomics England
  • Genomics Personalized Health (GPH)
  • Genomics, Inc
  • GenomOncology
  • Genzyme Corporation
  • Grail, Inc
  • Grifols
  • Guardant Health
  • Guardiome
  • HeiScreen
  • Helix
  • Helomics
  • Hologic
  • Horizon Discovery
  • HTG Molecular Diagnostics
  • Human Longevity, Inc. iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Macrogen
  • MDNA Life SCIENCES, Inc
  • MDx Health
  • Medgenome
  • Meridian Bioscience
  • Mesa Biotech
  • MIODx
  • miR Scientific
  • MNG Labs
  • Molecular MD
  • NantHealth, Inc
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • New Oncology
  • Novogene Bioinformatics Technology Co., Ltd
  • Omega Bioservices
  • OncoDNA
  • ORIG3N, Inc
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Panagene
  • Perkin Elmer
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • PrecisionMed
  • Promega
  • Protagen Diagnostics
  • Qiagen Gmbh
  • Quantumdx
  • Regeneron
  • Roche Molecular Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sequencing.com
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc
  • SkylineDx
  • Stratos Genomics
  • Sure Genomics, Inc
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc
  • Thermo Fisher Scientific Inc
  • Veritas Genetics
  • Volition
Note: Product cover images may vary from those shown
Adroll
adroll